↓ Skip to main content

Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid

Overview of attention for article published in Frontiers in immunology, January 2021
Altmetric Badge

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
21 Mendeley